EC
TWST icon

EdgeRock Capital’s Twist Bioscience TWST Stock Holding History

EdgeRock Capital’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-876
Closed -$43.2K – 274
2024
Q2 		$43.2K Buy
+876
New +$35.7K 0.03% 116
2024
Q1 		– Sell
-825
Closed -$30.2K – 291
2023
Q4 		$30.2K Buy
+825
New +$19.1K 0.02% 149

Other funds holding TWST

Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

EdgeRock Capital's TWST Position: Q3 2024 in Review

EdgeRock Capital sold out of Twist Bioscience (TWST) in Q3 2024, closing a stake of 876 shares — an estimated $43.2K sold.

EdgeRock Capital first reported a position in TWST in Q4 2023 and held it in 2 quarters. The position peaked at $43.2K in Q2 2024. 245 funds tracked by Wall St. Rank hold TWST as of Q3 2024.

  • EdgeRock Capital reported no remaining Twist Bioscience position as of Q3 2024 after selling out during the quarter.
  • EdgeRock Capital sold 876 Twist Bioscience shares in Q3 2024, an estimated $43.2K.
  • EdgeRock Capital first reported a position in Twist Bioscience in Q4 2023 and held it in 2 quarters.
  • EdgeRock Capital's Twist Bioscience position peaked at $43.2K in Q2 2024.
  • 245 funds tracked by Wall St. Rank held Twist Bioscience as of Q3 2024.

Based on EdgeRock Capital's 13F filing for Q3 2024, filed 15 Oct 2024.